Skip to main content
Clinical Trials/NCT02858648
NCT02858648
Completed
Not Applicable

Diabetes Go Mobile! - A Pilot Study Testing the Effect of a Behavioral Intervention With Smart Phone Based Self-Monitoring on Glycemic Control and Vascular Inflammatory Markers

The University of Texas Health Science Center, Houston1 site in 1 country26 target enrollmentJanuary 2013
ConditionsDiabetes

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Diabetes
Sponsor
The University of Texas Health Science Center, Houston
Enrollment
26
Locations
1
Primary Endpoint
Change in Weight as assessed by the Tanita Scale
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The purpose of this study is to examine whether a behavioral lifestyle intervention using mobile smart phone technology for self-monitoring can lead to greater improvements in diabetes outcomes.

Detailed Description

The investigators will conduct a pilot randomized controlled clinical trial to examine the feasibility and preliminary efficacy of a behavioral lifestyle intervention on weight, glycemic control, and vascular inflammatory marker outcomes. A total of 26 overweight or obese patients with type 2 diabetes will be recruited from an underserved minority community health center in Houston, TX. They were randomly assigned into one of the three groups: 1) Behavior intervention with smart phone based self-monitoring, 2) Behavior intervention with paper diary based self-monitoring, and 3) Usual care group. Both Mobile and Paper groups received a total of 11 group sessions and 1 individual session in a 6-month intervention. Mobile group received an android-based smart phone with two applications loaded to help them record their diet, physical activity, weight, and blood glucose, while the paper group is using paper diaries for these recordings.

Registry
clinicaltrials.gov
Start Date
January 2013
End Date
August 2013
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jing Wang

Associate Professor

The University of Texas Health Science Center, Houston

Eligibility Criteria

Inclusion Criteria

  • 21 to 74 years of age
  • BMI≥ 25 kg/m2
  • Self-reported being diagnosed with type 2 diabetes for at least 6 months
  • Currently monitor blood glucose and has a blood glucose meter
  • Be able to read and write in English

Exclusion Criteria

  • Previously participated in a structured lifestyle intervention, such as Look AHEAD in the last 12 months
  • Current pregnant /nursing or plan to become pregnant in the next 6 months
  • In addition to their diabetes condition, presence of a current serious illness or unstable condition requiring supervision on a special diet and limiting their ability to perform physical activity level.
  • Current treatment for a severe psychological disorder
  • Planned vacation, absences, or relocation in the next 6 months

Outcomes

Primary Outcomes

Change in Weight as assessed by the Tanita Scale

Time Frame: baseline, 3 months, 6 months

Change in Glycemic control as assessed by HbA1c levels

Time Frame: baseline, 3 months, 6 months

Secondary Outcomes

  • Change in Physical Activity as assessed by accelerometer(baseline, 3 months, 6 months)
  • Change in Dietary intake as measured by the Automated Self-administered 24-hour Dietary Recall (ASA24™) version 1(baseline, 3 months, 6 months)
  • Change in Physical Activity as assessed by IPAQ-Short Form(baseline, 3 months, 6 months)
  • Change in Blood pressure as assessed by automated blood pressure cuff(baseline, 3 months, 6 months)
  • Change in Waist circumference(baseline, 3 months, 6 months)
  • Change in Inflammation as assessed by C-reactive protein levels(baseline, 3 months, 6 months)
  • Change in Inflammation as assessed by IL-6 levels(baseline, 3 months, 6 months)
  • Percent attendance at group sessions(6 months)
  • Percent adherence to self-monitoring(6 months)
  • Change in Health literacy as measured by the Newest Vital Sign health literacy assessment(baseline, 3 months, 6 months)
  • Change in Depression as measured by the Center for Epidemiologic Studies Depression Scale (CES-D)(baseline, 3 months, 6 months)
  • Change in Diabetes Self-Care as Assessed by the Summary of Diabetes Self-Care Activities Expanded Version(baseline, 3 months, 6 months)
  • Change in Quality of life as assessed by the PROMIS Global(baseline, 3 months, 6 months)
  • Change in Clinical utility as assessed by the PROMIS 57(baseline, 3 months, 6 months)
  • Change in Perceived Stress as measured by the Perceived Stress Scale(baseline, 3 months, 6 months)
  • Change in Sleep Quality as assessed by the Pittsburgh Sleep Quality Index(baseline, 3 months, 6 months)
  • Change in Medication Adherence as assessed by the Morisky medication adherence questionnaire(baseline, 3 months, 6 months)
  • Change in Sleepiness. Assessed by the Epworth Sleepiness Scale(baseline, 3 months, 6 months)
  • Change in Self-efficacy for diabetes as assessed by the Self-efficacy for diabetes measure(baseline, 3 months, 6 months)

Study Sites (1)

Loading locations...

Similar Trials